NYSE:SNY

Sanofi Stock News

Healthcare > Drug Manufacturers - General

Buy SNY

*Your capital is at risk

$43.75

-0.230 (-0.523%)

At Close: Jul 21, 2026

Bpifrance eyes investment in Sanofi's consumer health business

12:37pm, Thursday, 04'th Jul 2024

Bpifrance Executive Director Jose Gonzalo said that the public investment bank is considering a potential investment in Sanofi's consumer health unit, Bloomberg News reported on Thursday.

Upcoming Stock Spinoffs: Should You Pounce or Pass?

12:00pm, Thursday, 04'th Jul 2024

Stock spinoffs typically don't do well initially. Unloved by shareholders of the former parent company, often misunderstood by the market and sometimes laden with debt or other baggage the parent no l

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

03:36pm, Wednesday, 03'rd Jul 2024

Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cl

7 Safe Haven Stocks to Buy Before the Next Market Correction

10:00am, Wednesday, 03'rd Jul 2024

Savvy investors must own safe haven stocks that provide stability and growth potential in an unstable economic environment. Recognizing which companies can withstand market declines becomes critical a

EU approves Sanofi's Dupixent for 'smoker's lungs'

01:11am, Wednesday, 03'rd Jul 2024

Sanofi and partner Regeneron on Wednesday won European Union approval for wider use of their Dupixent injection in patients with a chronic lung disease, a rare case of the EU clearing a drug faster th

Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

01:00am, Wednesday, 03'rd Jul 2024

Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two l

Sanofi eyes German insulin investment of up to $1.6 bln, source says

12:00pm, Monday, 01'st Jul 2024

French drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros ($1.4-$1.6 billion) to upgrade its production of long-acting insulin shots in Germany, a person famili

Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says

01:39am, Monday, 01'st Jul 2024

French drugmaker Sanofi is nearing a decision to invest between 1.3 billion euros and 1.5 billion euros ($1.4-$1.6 billion) at a major production site in Frankfurt, Germany, where it makes insulin bra

Verona Pharma Is Launching Ohtuvayre, Although There Will Be Competition

09:00am, Sunday, 30'th Jun 2024

VRNA received FDA approval for ensifentrine (Ohtuvayre) for the maintenance treatment of COPD on June 26. SNY/REGN's Dupixent represents a potential competitor. As do other drugs in development from S

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

08:02am, Thursday, 27'th Jun 2024

Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the common respiratory infecti

Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi

02:00am, Thursday, 27'th Jun 2024

- Sanofi to invest $40 million at an as-converted price of $7.44 per share of common stock- - Sanofi to receive an exclusive right of first negotiation for license of Company's small molecule TREM2 ag

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

05:30pm, Wednesday, 26'th Jun 2024

Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Majority of patients in this age group with eosinophilic esophagitis receiving Dupixen

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by